z-logo
open-access-imgOpen Access
Isolated v‐lesion represents a benign phenotype of vascular rejection of the kidney allograft – a retrospective study
Author(s) -
Novotny Marek,
Hruba Petra,
Vichova Petra,
Maluskova Jana,
Honsova Eva,
Viklicky Ondrej,
Wohlfahrtova Mariana
Publication year - 2018
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/tri.13286
Subject(s) - medicine , kidney transplantation , transplantation , biopsy , proteinuria , arteritis , lesion , gastroenterology , retrospective cohort study , nephrology , pathology , kidney , renal function , phenotype , urology , biochemistry , chemistry , gene
Summary While the detrimental impact of the humoral acute vascular rejection (AVR) phenotype is recognized, the prognostic significance of isolated v‐lesion (IV) remains unclear. In this retrospective single‐centre study, AVR was found in 98 of 1015 patients (9.7%) who had undergone kidney transplantation in 2010–2014, with donor‐specific antibodies (DSA) evaluated in all of them. The outcome of four AVR phenotypes was evaluated during median follow‐up of 59 months; in 25 patients with IV, 18 with T‐cell‐mediated vascular rejection (TCMVR), 19 with antibody‐mediated vascular rejection (AMVR) and 36 with suspected antibody‐mediated rejection (sAMVR). AVR was diagnosed mainly by for‐cause biopsy (81%) early after transplantation (median 19 POD) and appeared as mild‐grade intimal arteritis. IV occurred in low‐sensitized patients after the first transplantation (96%) in the absence of DSA. IV responded satisfactorily to treatment (88%), showed no persistence of rejection in surveillance biopsy, and had stable graft function, minimal proteinuria and excellent DCGS (96%). Contrary to that, Kaplan–Meier estimate of 3‐year DCGS of AMVR was 66% (log‐rank = 0.0004). Early IV represents a benign phenotype of AVR with a favourable outcome. This study prompts further research to evaluate the nature of IV before considering any change in the classification and management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here